Clinical Trial Update: Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

View source ↗

Summary

This trial update describes the development of a patient-reported outcome measure to assess symptoms in patients with primary sclerosing cholangitis (PSC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Snippet

Sponsor: Gilead Sciences | Conditions: Primary Sclerosing Cholangitis | Status: COMPLETED